Exercise study for myotonic dystrophy type 2
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital clinical trials.
This study tests if a structured exercise program is safe and helpful for people with myotonic dystrophy type 2 (DM2). It aims to improve strength and daily function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have a confirmed diagnosis of myotonic dystrophy type 2 (DM2).
- You must be able to walk without a cane, walker, or any help from another person.
- You must have had a normal heart test (ECG) within the last 3 months.
- Your body mass index (BMI) must be between 20 and 30.
- You must not have fallen in the last six months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is following people with myotonic dystrophy over 24 months to better understand the disease by combining past medical records already in a registry with new check-ups. It doesn't test a new treatment but helps researchers learn about the condition, which may lead to better care in the future.
This study builds a registry of people and families affected by myotonic dystrophy types 1 and 2. It helps researchers learn about the condition over time and may support future studies that could lead to better care.
This study collects blood and, for some people, muscle tissue to look for signs (biomarkers) that can help track and better understand myotonic dystrophy. You may help by providing samples and basic muscle function testing, depending on your age and condition type.
This study uses MRI scans to measure muscle changes in people with myotonic dystrophy (DM1 or DM2) and healthy volunteers. The goal is to find better ways to track the disease over time.
This study uses scans and other tests to understand how brain structure relates to symptoms in people with myotonic dystrophy type 1 or type 2. It may help researchers connect measurable brain changes to movement and other clinical outcomes.
This study follows people with myotonic dystrophy type 1 (DM1) over time to learn more about how the disease progresses. It collects health information and samples to help improve care.
Hear when a new Myotonic Dystrophy 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.